David Scott Jones, SVP & Chief Commercial Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 52,034 shares at $25.27 ($1.3M) on 2024-01-26, disclosed to the SEC on 2024-01-29.
Scheduled sale ($1.3M) by SVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.27 | 9,604 | $243K | 18.4% |
| 2 | $25.27 | 9,604 | $243K | 18.4% |
| 3 | $25.45 | 16,413 | $418K | 31.6% |
| 4 | $25.45 | 16,413 | $418K | 31.6% |
| Total | $25.38 avg | 52,034 | $1.3M | 100% |
| Filing → |
| EYPT | SELL | 2024-01-24 | $1.6M | — | Filing → |